Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ROSI CHARNI AS
AS
Active
Org 924944102
Tjørnhaugen 50, 5154 Bønes
Economic activity was not specified by tax authority · NACE 0000
Est. 2020
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 4,4M
+324% vs 2023
EBITDA margin
71.2%
+296% vs 2023
Equity ratio
66.9%
Financial strength
Net profit 2024
NOK 2,4M
+297% vs 2023
EBITDA — year on year
NOK millions
4M
3M
2M
1M
0M
2M
2020
0M
-100%
2021
1M
+100%
2022
1M
0%
2023
3M
+200%
2024
Key figures
Annual report 2024
Revenue
NOK 4,4M
+324%
EBITDA
NOK 3,1M
+296%
Net profit
NOK 2,4M
+297%
Total assets
NOK 7,2M
+86%
Equity
NOK 4,8M
+100%
Employees
0
—
Company information
Legal name
ROSI CHARNI AS
Org number
924944102
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
20. april 2020
Share capital
NOK 60 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Investeringer i små bedrifter og oppstartsbedrifter med bioteknologi.
Contact
Address
Tjørnhaugen 50, 5154 Bønes
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Economic activity was not specified by tax authority
Companies in Bergen
All Norway companies
Revenue
NOK millions
0M
1M
2M
3M
5M
2M
2020
1M
2021
1M
2022
1M
2023
4M
2024
EBITDA
NOK millions
0M
1M
2M
3M
3M
2M
2020
0M
2021
1M
2022
1M
2023
3M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
1 611
704
967
1 041
4 415
Staff expenses
−0
−0
−0
−0
−11
EBITDA
1 611
496
778
793
3 143
Depreciation & amort.
−0
−0
−0
−0
−11
EBIT
1 611
496
778
793
3 132
Net financials
0
0
0
−9
−17
Profit before tax
1 611
496
779
784
3 115
Tax
353
109
172
174
691
Net profit
1 258
387
606
610
2 424
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 689
2 844
3 825
3 889
7 232
Equity
1 312
1 399
1 905
2 415
4 839
Long-term debt
0
0
0
0
1 275
Short-term debt
1 376
1 445
1 920
1 473
1 118
Total debt
1 376
1 445
1 920
1 473
2 393
Financial ratios
5-year trend
EBITDA margin
71.2%
This company
15.8%
Market median
+351% vs market
2020
2024
Equity ratio
66.9%
This company
38.2%
Market median
+75% vs market
2020
2024
Return on equity
50.1%
This company
18.4%
Market median
+172% vs market
2020
2024
Net profit margin
54.9%
This company
8.1%
Market median
+578% vs market
2020
2024
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
2020
2024
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-03-09 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
RK
Rolf Kristian Berge
Chairman
2020
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Nils Øyvind Berge
Individual
20%
20%
2022
Arvid Berge
Individual
20%
20%
2022
Christ Berge
Individual
20%
20%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
ROSI CHARNI AS
(this company)
LIPCLINE AS
Enedria As
MITOMED AS
NOBESITA AS
Board network connections
Board members of ROSI CHARNI AS also hold positions in
0
other companies.
Person
Role here
Other companies
Rolf Kristian Berge
Chairman
0 companies